1. Home
  2. AWH vs BOF Comparison

AWH vs BOF Comparison

Compare AWH & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWH
  • BOF
  • Stock Information
  • Founded
  • AWH 1993
  • BOF 2017
  • Country
  • AWH United States
  • BOF United States
  • Employees
  • AWH N/A
  • BOF N/A
  • Industry
  • AWH Medical/Dental Instruments
  • BOF Packaged Foods
  • Sector
  • AWH Health Care
  • BOF Consumer Staples
  • Exchange
  • AWH Nasdaq
  • BOF Nasdaq
  • Market Cap
  • AWH 13.5M
  • BOF 12.5M
  • IPO Year
  • AWH N/A
  • BOF 2023
  • Fundamental
  • Price
  • AWH $0.75
  • BOF $1.95
  • Analyst Decision
  • AWH Buy
  • BOF
  • Analyst Count
  • AWH 2
  • BOF 0
  • Target Price
  • AWH $4.40
  • BOF N/A
  • AVG Volume (30 Days)
  • AWH 139.7K
  • BOF 685.0K
  • Earning Date
  • AWH 11-14-2024
  • BOF 11-26-2024
  • Dividend Yield
  • AWH N/A
  • BOF N/A
  • EPS Growth
  • AWH N/A
  • BOF N/A
  • EPS
  • AWH N/A
  • BOF N/A
  • Revenue
  • AWH $8,923,000.00
  • BOF $6,489,951.00
  • Revenue This Year
  • AWH $15.56
  • BOF N/A
  • Revenue Next Year
  • AWH $105.32
  • BOF N/A
  • P/E Ratio
  • AWH N/A
  • BOF N/A
  • Revenue Growth
  • AWH N/A
  • BOF 703.78
  • 52 Week Low
  • AWH $0.72
  • BOF $0.61
  • 52 Week High
  • AWH $5.65
  • BOF $4.11
  • Technical
  • Relative Strength Index (RSI)
  • AWH 33.23
  • BOF 59.06
  • Support Level
  • AWH $0.84
  • BOF $1.72
  • Resistance Level
  • AWH $0.87
  • BOF $2.20
  • Average True Range (ATR)
  • AWH 0.09
  • BOF 0.15
  • MACD
  • AWH -0.02
  • BOF 0.04
  • Stochastic Oscillator
  • AWH 12.87
  • BOF 63.24

About AWH Aspira Women's Health Inc.

Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

About BOF BranchOut Food Inc.

Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are primarily located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.

Share on Social Networks: